A network analysis to identify pathophysiological pathways distinguishing ischaemic from non‐ischaemic heart failure
Open Access
- 3 April 2020
- journal article
- research article
- Published by Wiley in European Journal of Heart Failure
- Vol. 22 (5), 821-833
- https://doi.org/10.1002/ejhf.1811
Abstract
Aims Heart failure (HF) is frequently caused by an ischaemic event (e.g. myocardial infarction) but might also be caused by a primary disease of the myocardium (cardiomyopathy). In order to identify targeted therapies specific for either ischaemic or non‐ischaemic HF, it is important to better understand differences in underlying molecular mechanisms. Methods and results We performed a biological physical protein–protein interaction network analysis to identify pathophysiological pathways distinguishing ischaemic from non‐ischaemic HF. First, differentially expressed plasma protein biomarkers were identified in 1160 patients enrolled in the BIOSTAT‐CHF study, 715 of whom had ischaemic HF and 445 had non‐ischaemic HF. Second, we constructed an enriched physical protein–protein interaction network, followed by a pathway over‐representation analysis. Finally, we identified key network proteins. Data were validated in an independent HF cohort comprised of 765 ischaemic and 100 non‐ischaemic HF patients. We found 21/92 proteins to be up‐regulated and 2/92 down‐regulated in ischaemic relative to non‐ischaemic HF patients. An enriched network of 18 proteins that were specific for ischaemic heart disease yielded six pathways, which are related to inflammation, endothelial dysfunction superoxide production, coagulation, and atherosclerosis. We identified five key network proteins: acid phosphatase 5, epidermal growth factor receptor, insulin‐like growth factor binding protein‐1, plasminogen activator urokinase receptor, and secreted phosphoprotein 1. Similar results were observed in the independent validation cohort. Conclusions Pathophysiological pathways distinguishing patients with ischaemic HF from those with non‐ischaemic HF were related to inflammation, endothelial dysfunction superoxide production, coagulation, and atherosclerosis. The five key pathway proteins identified are potential treatment targets specifically for patients with ischaemic HF.This publication has 47 references indexed in Scilit:
- Metalloproteinase-mediated Shedding of Integrin β2 Promotes Macrophage Efflux from Inflammatory SitesOnline Journal of Public Health Informatics, 2012
- The IntAct molecular interaction database in 2012Nucleic Acids Research, 2011
- The role of macrophage-derived urokinase plasminogen activator in myocardial infarct repair: Urokinase attenuates ventricular remodelingJournal of Molecular and Cellular Cardiology, 2010
- Measuring the physical cohesiveness of proteins using physical interaction enrichmentBioinformatics, 2010
- Osteopontin: Role in extracellular matrix deposition and myocardial remodeling post-MIJournal of Molecular and Cellular Cardiology, 2010
- ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networksBioinformatics, 2009
- High insulinlike growth factor binding protein 1 level predicts incident congestive heart failure in the elderlyAmerican Heart Journal, 2008
- BioGRID: a general repository for interaction datasetsNucleic Acids Research, 2006
- Development of Human Protein Reference Database as an Initial Platform for Approaching Systems Biology in HumansGenome Research, 2003
- BIND: the Biomolecular Interaction Network DatabaseNucleic Acids Research, 2003